UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson's Disease

-- UCB to partner with Novartis on development of UCB0599 with an opt-in to develop UCB7853, two innovative and potentially disease-modifying investigational assets in Parkinson's disease --

Related Keywords

Japan ,Brussels ,Bruxelles Capitale ,Belgium ,Dhaval Patel ,Charl Van Zyl ,Neurology Head Of Europe International ,Neuropore Therapies Inc ,Novartis ,Executive Vice President ,Chief Scientific Officer ,International Markets ,Neuropore Therapies ,Announces ,Lobal ,Partnership ,Ring ,Disease ,Modifying ,Therapies ,People ,Diving ,Ith ,Parkinson ,